Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
RMD	RESMED INC	United States	$32.03B	146,907,207	54.56%	4.31%	Net Selling	Net Selling
ATRC	ATRICURE INC	United States	$1.10B	47,587,966	75.23%	24.77%	Net Selling	Net Selling
SCYX	SCYNEXIS INC	United States	$58.14M	37,753,481	43.75%	21.70%	Net Selling	Net Selling
ENSG	ENSIGN GROUP INC	United States	$6.64B	56,665,741	60.07%	39.93%	Net Selling	Net Selling
AVRO	AVROBIO INC	United States	$54.28M	44,860,515	46.76%	53.24%	Net Selling	Net Selling
NHC	NATIONAL HEALTHCARE CORP	United States	$1.40B	15,349,989	56.40%	32.10%	Net Buying	Net Buying
SPRO	SPERO THERAPEUTICS INC	United States	$78.65M	53,869,139	25.60%	64.13%	Net Selling	Net Selling
MMSI	MERIT MEDICAL SYSTEMS INC	United States	$4.27B	57,930,050	94.92%	5.08%	Net Buying	Net Selling
FTLF	FITLIFE BRANDS INC	United States	$132.08M	4,598,241	0.86%	99.14%	Net Buying
CPRX	CATALYST PHARMACEUTICALS INC	United States	$1.75B	117,863,258	71.64%	16.33%	Net Buying	Net Buying
ANIP	ANI PHARMACEUTICALS INC	United States	$1.38B	21,078,986	21.94%	78.06%	Net Selling	Net Selling
VRTX	VERTEX PHARMACEUTICALS INC	United States	$102.67B	258,307,816	90.91%	1.48%	Net Selling	Net Selling
KRYS	KRYSTAL BIOTECH INC	United States	$4.44B	28,292,616	75.55%	24.45%	Net Selling	Net Selling
NEOG	NEOGEN CORP	United States	$2.63B	216,607,746	98.55%	1.45%	Net Buying	Net Buying
HSTM	HEALTHSTREAM INC	United States	$778.49M	30,397,886	69.30%	24.81%	Net Selling	Net Selling
PFE	PFIZER INC	United States	$143.43B	5,646,778,425	68.45%	0.27%	Net Selling	Net Selling
HAE	HAEMONETICS CORP	United States	$4.62B	50,786,117	97.49%	2.51%	Net Buying	Net Selling
CRSP	CRISPR THERAPEUTICS AG	Switzerland	$4.33B	80,275,950	62.44%	37.56%	Net Buying	Net Buying
SY	SO-YOUNG INTERNATIONAL INC	China	$123.05M	75,422,436	11.12%	0.00%
FMS	FRESENIUS MEDICAL CARE AG	Germany	$11.80B	293,413,449	11.30%	0.00%
IDXX	IDEXX LABORATORIES INC	United States	$41.49B	83,089,381	87.71%	1.68%	Net Selling	Net Selling
TMO	THERMO FISHER SCIENTIFIC INC	United States	$218.72B	381,312,268	89.26%	0.87%	Net Selling	Net Selling
ATRI	ATRION CORP	United States	$695.15M	1,759,836	56.66%	43.34%	Net Buying	Net Selling
RCM	R1 RCM INC	United States	$5.00B	420,280,234	47.62%	52.38%	Net Selling	Net Selling
QGEN	QIAGEN NV	Netherlands	$9.50B	228,202,755	61.40%	0.00%
RPID	RAPID MICRO BIOSYSTEMS INC	United States	$40.20M	42,497,413	47.28%	50.76%	Net Buying	Net Selling
CNMD	CONMED CORP	United States	$2.03B	30,800,747	97.43%	2.57%	Net Buying	Net Buying
RDY	DR REDDYS LABORATORIES LTD	India	$12.41B	166,527,876	14.05%	0.00%
HSIC	HENRY SCHEIN INC	United States	$9.40B	128,505,719	96.06%	3.94%	Net Selling	Net Selling
LLY	ELI LILLY & CO	United States	$696.96B	950,164,452	82.44%	11.18%	Net Selling	Net Selling
TFFP	TFF PHARMACEUTICALS INC	United States	$7.36M	2,519,220	3.17%	96.83%	Net Buying
A	AGILENT TECHNOLOGIES INC	United States	$40.37B	293,055,284	87.43%	1.18%	Net Buying	Net Selling
SEER	SEER INC	United States	$123.72M	64,773,180	54.70%	45.30%	Net Buying	Net Selling
SPOK	SPOK HOLDINGS INC	United States	$319.36M	20,136,491	27.02%	72.98%	Net Selling	Net Selling
AXNX	AXONICS INC	United States	$3.40B	51,003,429	56.63%	43.37%	Net Selling	Net Selling
AXGN	AXOGEN INC	United States	$286.46M	43,206,246	54.13%	45.87%	Net Selling	Net Selling
BWAY	BRAINSWAY LTD	Israel	$79.12M	33,242,189	13.01%	0.00%
SYK	STRYKER CORP	United States	$127.62B	380,264,036	45.77%	54.23%	Net Selling	Net Selling
KNSA	KINIKSA PHARMACEUTICALS LTD	Bermuda	$1.27B	70,940,145	48.25%	9.83%	Net Selling	Net Selling
OCUP	OCUPHIRE PHARMA INC	United States	$39.95M	24,813,370	1.23%	98.77%	Net Buying	Net Buying
BDX	BECTON DICKINSON & CO	United States	$66.90B	288,902,232	86.97%	0.63%	Net Selling	Net Selling
SOPH	SOPHIA GENETICS SA	Switzerland	$328.11M	65,230,559	26.43%	0.00%
ENZ	ENZO BIOCHEM INC	United States	$53.79M	51,225,734	31.93%	48.12%	Net Selling
SWAV	SHOCKWAVE MEDICAL INC	United States	$12.34B	37,396,816	79.54%	20.46%	Net Selling	Net Selling
USPH	U S PHYSICAL THERAPY INC	United States	$1.52B	15,068,426	92.04%	7.96%	Net Selling	Net Selling
ADAG	ADAGENE INC	China	$105.44M	55,145,839	12.92%	0.00%
DGX	QUEST DIAGNOSTICS INC	United States	$14.92B	111,091,574	87.75%	1.76%	Net Selling	Net Selling
LH	LABORATORY CORP OF AMERICA HOLDINGS	United States	$16.69B	84,100,000	95.77%	1.52%	Net Selling	Net Selling
MIRM	MIRUM PHARMACEUTICALS INC	United States	$1.15B	47,003,329	48.94%	51.06%	Net Buying	Net Selling
NVO	NOVO NORDISK A S	Denmark	$572.09B	4,510,000,000	6.84%	0.00%
SUPN	SUPERNUS PHARMACEUTICALS INC	United States	$1.65B	54,734,956	45.35%	54.65%	Net Selling	Net Selling
MEDP	MEDPACE HOLDINGS INC	United States	$12.27B	30,983,399	27.34%	72.66%	Net Selling	Net Selling
ITGR	INTEGER HOLDINGS CORP	United States	$3.67B	33,503,719	95.54%	4.46%	Net Selling	Net Selling
LFWD	LIFEWARD LTD	Israel	$40.36M	8,497,162	8.06%	91.94%	Net Buying
VREX	VAREX IMAGING CORP	United States	$671.60M	40,000,000	98.75%	1.25%	Net Selling	Net Selling
SNN	SMITH & NEPHEW PLC	United Kingdom	$10.73B	877,672,643	3.64%	0.00%
BSX	BOSTON SCIENTIFIC CORP	United States	$107.35B	1,467,095,627	90.84%	5.78%	Net Selling	Net Selling
PDCO	PATTERSON COMPANIES INC	United States	$2.31B	89,592,000	83.44%	16.56%	Net Buying	Net Buying
AMGN	AMGEN INC	United States	$144.69B	535,918,901	76.49%	1.01%	Net Selling	Net Selling
CSTL	CASTLE BIOSCIENCES INC	United States	$558.33M	27,449,983	84.19%	15.81%	Net Selling	Net Selling
ELMD	ELECTROMED INC	United States	$135.70M	8,605,227	19.72%	80.28%	Net Buying	Net Buying
PAHC	PHIBRO ANIMAL HEALTH CORP	United States	$515.61M	40,503,608	44.77%	55.23%
ALKS	ALKERMES PLC	Ireland	$4.12B	167,076,133	93.61%	6.39%	Net Selling	Net Selling
STVN	STEVANATO GROUP SPA	Italy	$8.14B	295,540,036	11.70%	0.00%
VTGN	VISTAGEN THERAPEUTICS INC	United States	$128.37M	27,025,209	38.92%	61.08%	Net Buying
FORA	FORIAN INC	United States	$84.68M	31,131,835	13.30%	57.67%	Net Buying	Net Selling
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	Israel	$67.46M	11,452,672	12.49%	0.00%
JAZZ	JAZZ PHARMACEUTICALS PLC	Ireland	$6.82B	62,345,283	26.94%	73.06%	Net Selling	Net Selling
VYNE	VYNE THERAPEUTICS INC	United States	$35.25M	14,098,888	23.19%	76.81%	Net Buying	Net Selling
NSPR	INSPIREMD INC	Israel	$46.91M	23,456,590	31.64%	68.36%	Net Buying
SIBN	SI-BONE INC	United States	$598.31M	41,064,511	56.69%	43.31%	Net Selling	Net Selling
SGHT	SIGHT SCIENCES INC	United States	$261.64M	49,553,371	33.61%	55.04%	Net Selling	Net Selling
IDYA	IDEAYA BIOSCIENCES INC	United States	$2.98B	74,560,273	88.70%	10.03%	Net Selling	Net Selling
SHC	SOTERA HEALTH CO	United States	$3.22B	282,832,200	61.96%	38.04%	Net Selling	Net Selling
PRTA	PROTHENA CORP PUBLIC LTD CO	Ireland	$1.12B	53,720,455	53.06%	46.94%	Net Buying
AKLI	AKILI INC	United States	$19.23M	78,509,823	43.14%	56.86%	Net Selling	Net Selling
CRON	CRONOS GROUP INC	Canada	$987.56M	381,298,853	8.71%	48.47%	Net Buying	Net Selling
IMMP	IMMUTEP LTD	Australia	$315.04M	1,188,834,559	0.17%	0.00%
RNA	AVIDITY BIOSCIENCES INC	United States	$1.94B	79,719,473	82.47%	17.53%	Net Selling	Net Selling
EHC	ENCOMPASS HEALTH CORP	United States	$8.26B	100,140,031	93.92%	6.08%	Net Selling	Net Selling
AGIO	AGIOS PHARMACEUTICALS INC	United States	$1.77B	56,194,847	75.09%	24.91%	Net Selling	Net Selling
CVRX	CVRX INC	United States	$307.43M	20,927,729	36.38%	63.62%	Net Buying	Net Buying
KZR	KEZAR LIFE SCIENCES INC	United States	$58.61M	72,801,359	67.83%	21.82%	Net Buying
ORMP	ORAMED PHARMACEUTICALS INC	United States	$99.68M	40,519,160	12.73%	46.50%
AKYA	AKOYA BIOSCIENCES INC	United States	$186.73M	49,140,731	30.03%	52.24%	Net Buying	Net Selling
ALGS	ALIGOS THERAPEUTICS INC	United States	$59.17M	75,668,521	54.25%	45.75%	Net Buying
INM	INMED PHARMACEUTICALS INC	Canada	$1.39M	6,056,970	13.28%	11.17%	Net Buying	Net Buying
GNFT	GENFIT SA	France	$173.92M	49,834,983	1.27%	0.00%
INSP	INSPIRE MEDICAL SYSTEMS INC	United States	$7.02B	29,585,104	64.70%	35.30%	Net Buying	Net Selling
ELV	ELEVANCE HEALTH INC	United States	$124.87B	232,417,867	89.35%	2.58%	Net Selling	Net Selling
HYPR	HYPERFINE INC	United States	$60.80M	71,950,433	14.95%	36.66%	Net Selling	Net Selling
EKSO	EKSO BIONICS HOLDINGS INC	United States	$22.38M	17,903,128	4.27%	95.73%	Net Selling
MDWD	MEDIWOUND LTD	Israel	$168.20M	9,221,764	27.28%	0.00%
LPCN	LIPOCINE INC	United States	$25.51M	5,315,830	5.77%	94.23%	Net Buying
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	United States	$714.60M	26,915,243	87.10%	12.90%	Net Selling	Net Selling
ACCD	ACCOLADE INC	United States	$618.24M	78,356,908	70.12%	29.88%	Net Buying	Net Selling
ABBV	ABBVIE INC	United States	$281.96B	1,766,473,359	70.16%	0.15%	Net Selling	Net Selling
TWST	TWIST BIOSCIENCE CORP	United States	$1.82B	57,818,022	88.25%	11.75%	Net Selling	Net Selling
ZLAB	ZAI LAB LTD	China	$1.58B	992,087,430	4.15%	1.96%	Net Buying	Net Buying
OM	OUTSET MEDICAL INC	United States	$121.21M	50,505,683	85.44%	14.56%	Net Selling	Net Selling

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	682	+1.20%	+1.13%	-9.62%	-22.18%	14.88x	5.85x	-68.98%	+2.75%	+21.30%	+91.72%	Strong Buy
Diagnostics & Research	66	+0.75%	+4.09%	-5.10%	-0.74%	38.49x	4.18x	-21.75%	+6.53%	+11.20%	+10.85%	Buy
Drug Manufacturers - General	17	+0.34%	+1.38%	-4.08%	+12.78%	159.81x	6.13x	+32.60%	+7.65%	+14.35%	+15.95%	Buy
Drug Manufacturers - Specialty & Generic	90	+0.98%	+2.24%	-2.72%	-6.94%	33.92x	2.09x	+11.56%	+2.78%	+5.22%	+37.77%	Strong Buy
Healthcare Plans	12	-0.85%	-2.11%	-4.78%	+3.59%	18.86x	2.91x	+20.02%	+6.15%	+14.19%	+16.44%	Buy
Health Information Services	61	+0.87%	+0.45%	-8.40%	-24.77%	72.49x	3.38x	+6.61%	+2.33%	+5.91%	+38.22%	Buy
Medical Care Facilities	50	-0.63%	-0.25%	-6.53%	+3.06%	-1.17x	4.49x	-87.35%	+6.17%	+13.08%	+19.34%	Buy
Medical Devices	154	+0.28%	+1.14%	-4.31%	-15.96%	28.63x	3.70x	+10.75%	+5.35%	+7.78%	+22.71%	Buy
Medical Distribution	9	+0.52%	+1.70%	-0.69%	+37.51%	26.24x	147.94x	+18.14%	+3.52%	+19.64%	+3.58%	Buy
Medical Instruments & Supplies	56	+1.23%	+1.70%	-4.37%	-11.53%	48.29x	3.53x	+11.70%	+7.83%	+10.36%	+19.66%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top healthcare stock with a Zen Score of 75, which is 50 points higher than the healthcare sector average of 25. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other healthcare stocks by -20 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other healthcare stocks by 3 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -0.61% over the past year, overperforming other healthcare stocks by 10 percentage points.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.84%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 55 percentage points higher than the healthcare sector average of 2.84%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.95%, which is 9 percentage points higher than the healthcare sector average of 2.84%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.62% in the last day, and up 1.39% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -53.19% in the past year. It has underperformed other stocks in the healthcare sector by -43 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -40.25% in the past year. It has underperformed other stocks in the healthcare sector by -30 percentage points.

3. Orasure Technologies (NASDAQ:OSUR)

Orasure Technologies (NASDAQ:OSUR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Orasure Technologies's stock has dropped -19.88% in the past year. It has underperformed other stocks in the healthcare sector by -10 percentage points.

Are healthcare stocks a good buy now?

47.45% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.39% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 74.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.